Silo Pharma Stock Alpha and Beta Analysis
| SILO Stock | USD 0.86 0.05 5.49% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Silo Pharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Silo Pharma over a specified time horizon. Remember, high Silo Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Silo Pharma's market risk premium analysis include:
Beta (0.13) | Alpha (0.60) | Risk 4.78 | Sharpe Ratio (0.09) | Expected Return (0.45) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Silo |
Silo Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Silo Pharma market risk premium is the additional return an investor will receive from holding Silo Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Silo Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Silo Pharma's performance over market.| α | -0.6 | β | -0.13 |
Silo Pharma expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Silo Pharma's Buy-and-hold return. Our buy-and-hold chart shows how Silo Pharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Silo Pharma Market Price Analysis
Market price analysis indicators help investors to evaluate how Silo Pharma otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Silo Pharma shares will generate the highest return on investment. By understating and applying Silo Pharma otc stock market price indicators, traders can identify Silo Pharma position entry and exit signals to maximize returns.
Silo Pharma Return and Market Media
The median price of Silo Pharma for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 1.11 with a coefficient of variation of 10.11. The daily time series for the period is distributed with a sample standard deviation of 0.11, arithmetic mean of 1.13, and mean deviation of 0.09. The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Silo Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Silo or other otcs. Alpha measures the amount that position in Silo Pharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Silo Pharma Upcoming Company Events
As portrayed in its financial statements, the presentation of Silo Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Silo Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Silo Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Silo Pharma. Please utilize our Beneish M Score to check the likelihood of Silo Pharma's management manipulating its earnings.
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Silo Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Other Information on Investing in Silo OTC Stock
Silo Pharma financial ratios help investors to determine whether Silo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Silo with respect to the benefits of owning Silo Pharma security.